Predictors for the utilization of social service counseling by prostate cancer patients.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 10 05 2021
accepted: 08 10 2021
pubmed: 6 11 2021
medline: 1 2 2022
entrez: 5 11 2021
Statut: ppublish

Résumé

Social service counseling (SSC) is an important instrument to support cancer patients, for example, regarding legal support, or rehabilitation. Several countries have established on-site SSC in routine care. Previous analyses have shown that SSC utilization varies across cancer centers. This analysis investigates patient and center-level predictors that explain variations in SSC utilization between centers. Logistic multilevel analysis was performed with data from 19,865 prostate cancer patients from 102 prostate cancer centers in Germany and Switzerland. Data was collected within an observational study between July 2016 and June 2020 using survey (online and paper) and tumor documentation. The intraclass correlation coefficient for the null model implies that 51% of variance in SSC utilization is attributable to the center a patient is treated in. Patients aged 80 years and older, with higher education, private insurance, without comorbidities, localized intermediate risk, and undergoing androgen deprivation therapy before study inclusion were less likely to utilize SSC. Undergoing primary radiotherapy, active surveillance, or watchful waiting as compared to prostatectomy was associated with a lower likelihood of SSC utilization. Significant negative predictors at the center level were university hospital, center's location in Switzerland, and a short period of certification. The results show that patient and center characteristics contribute to explaining the variance in SSC utilization in prostate cancer centers to a large extent. The findings may indicate different organizational processes in the countries included and barriers in the sectoral structure of the healthcare system. In-depth analyses of processes within cancer centers may provide further insights into the reasons for variance in SSC utilization.

Identifiants

pubmed: 34738162
doi: 10.1007/s00520-021-06620-z
pii: 10.1007/s00520-021-06620-z
pmc: PMC8568309
doi:

Substances chimiques

Androgen Antagonists 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2327-2339

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Ferlay J, Colombet M, Soerjomataram I et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387. https://doi.org/10.1016/j.ejca.2018.07.005
doi: 10.1016/j.ejca.2018.07.005 pubmed: 30100160
Robert Koch-Institut (2019) Krebs in Deutschland für 2015/2016. https://doi.org/10.25646/5977
King AJ, Evans M, Moore TH et al (2015) Prostate cancer and supportive care: a systematic review and qualitative synthesis of men’s experiences and unmet needs. Eur J Cancer Care (Engl) 24:618–634. https://doi.org/10.1111/ecc.12286
doi: 10.1111/ecc.12286
Paterson C, Robertson A, Smith A, Nabi G (2015) Identifying the unmet supportive care needs of men living with and beyond prostate cancer: a systematic review. Eur J Oncol Nurs 19:405–418. https://doi.org/10.1016/j.ejon.2014.12.007
doi: 10.1016/j.ejon.2014.12.007 pubmed: 25613370
Wright P, Wilding S, Watson E et al (2019) Key factors associated with social distress after prostate cancer: results from the United Kingdom Life after Prostate Cancer diagnosis study. Cancer Epidemiol 60:201–207. https://doi.org/10.1016/j.canep.2019.04.006
doi: 10.1016/j.canep.2019.04.006 pubmed: 31071525
Watson E, Shinkins B, Frith E et al (2016) Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up. BJU Int 117:E10–E19. https://doi.org/10.1111/bju.13122
doi: 10.1111/bju.13122 pubmed: 25818406
Hyde MK, Newton RU, Galvão DA et al (2017) Men’s help-seeking in the first year after diagnosis of localised prostate cancer. Eur J Cancer Care (Engl) 26:e12497. https://doi.org/10.1111/ecc.12497
doi: 10.1111/ecc.12497
Dettmers S, Uhrig A, Voigt M, et al (2018) Expertenstandard Psychosoziale Erstberatung onkologischer Patient*innen in der stationären Versorgung (PEOPSA). Arbeitsgemeinschaft für Soziale Arbeit in der Onkologie (ASO), Deutsche Vereinigung für Soziale Arbeit im Gesundheitswesen e.V. (DVSG), Deutsche Krebsgesellschaft e.V., Berlin
Kowalski C, Pfaff H, Halbach SM et al (2019) Sozialdienstliche Beratungsquoten und Informationsbedarfe bei BrustkrebspatientInnen – eine Mehrebenenanalyse mit PatientInnenbefragungs- und -auditdaten. In: Sagebiel J, Hammerschmidt P, Janßen C (eds) Quantitative Forschung in der Sozialen Arbeit. Beltz Juventa, Weinheim, pp 130–148
Kowalski C, Ferencz J, Singer S et al (2016) Frequency of psycho-oncologic and social service counseling in cancer centers relative to center site and hospital characteristics: Findings from 879 center sites in Germany, Austria, Switzerland, and Italy. Cancer. https://doi.org/10.1002/cncr.30202
doi: 10.1002/cncr.30202 pubmed: 27481151
Kowalski C, Ferencz J, Weis I et al (2015) Social service counseling in cancer centers certified by the german cancer society. Soc Work Health Care 54:307–319. https://doi.org/10.1080/00981389.2014.999980
doi: 10.1080/00981389.2014.999980 pubmed: 25905764
Lilliehorn S, Isaksson J, Salander P (2019) What does an oncology social worker deal with in patient consultations? - An empirical study. Soc Work Health Care 58:494–508. https://doi.org/10.1080/00981389.2019.1587661
doi: 10.1080/00981389.2019.1587661 pubmed: 30901286
Pockett R, Dzidowska M, Hobbs K (2015) Social work intervention research with adult cancer patients: a literature review and reflection on knowledge-building for practice. Soc Work Health Care 54:582–614. https://doi.org/10.1080/00981389.2015.1046577
doi: 10.1080/00981389.2015.1046577 pubmed: 26317763
Holm LV, Hansen DG, Johansen C et al (2012) Participation in cancer rehabilitation and unmet needs: a population-based cohort study. Support Care Cancer 20:2913–2924. https://doi.org/10.1007/s00520-012-1420-0
doi: 10.1007/s00520-012-1420-0 pubmed: 22415608 pmcid: 3461205
Gray RE, Goel V, Fitch MI et al (2000) Utilization of professional supportive care services by women with breast cancer. Breast Cancer Res Treat 64:253–258. https://doi.org/10.1023/A:1026548320063
doi: 10.1023/A:1026548320063 pubmed: 11200775
Gadalla TM (2007) Cancer patients’ use of social work services in Canada: prevalence, profile, and predictors of use. Health Soc Work 32:189–196. https://doi.org/10.1093/hsw/32.3.189
doi: 10.1093/hsw/32.3.189 pubmed: 17896675
Abbott YK (2016) Breast cancer patient access to social work. J Soc Work 17:531–543. https://doi.org/10.1177/1468017316649331
doi: 10.1177/1468017316649331
Andersen RM, Davidson PL, Baumeister SE (2014) Improving access to care. In: Kominski G (ed) Changing the US health care system: key issues in health services policy and management. Wiley & Sons, San Fransisco, CA, pp 33–69
von Lengerke T, Gohl D, Babitsch B (2014) Re-revisiting the behavioral model of health care utilization by Andersen: a review on theoretical advances and perspectives. In: Janssen C, Swart E, von Lengerke T (eds) Health Care Utilization in Germany. Springer, New York, pp 11–28
doi: 10.1007/978-1-4614-9191-0_2
Kowalski C, Roth R, Carl G et al (2020) A multicenter paper-based and web-based system for collecting patient-reported outcome measures in patients undergoing local treatment for prostate cancer: first experiences. J Patient-Rep Outcomes 4:56. https://doi.org/10.1186/s41687-020-00224-7
doi: 10.1186/s41687-020-00224-7 pubmed: 32661594 pmcid: 7359206
Martin NE, Massey L, Stowell C et al (2014) Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol. https://doi.org/10.1016/j.eururo.2014.08.075
doi: 10.1016/j.eururo.2014.08.075 pubmed: 25234359 pmcid: 4410300
Leitlinienprogramm Onkologie (2019) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. (Version 5.1). Leitlinienprogramm Onkologie, Berlin
Breidenbach C, Wesselmann S, Sibert NT et al (2021) Use of social service counseling by cancer patients: an analysis of quality assurance data of 6339 breast cancer patients from 13 certified centers in Germany treated between 2015 and 2017. BMC Cancer 21:1–9. https://doi.org/10.1186/s12885-021-08396-1
doi: 10.1186/s12885-021-08396-1
Breidenbach C, Roth R, Ansmann L et al (2020) Use of psycho-oncological services by prostate cancer patients: a multilevel analysis. Cancer Med 9:3680–3690. https://doi.org/10.1002/cam4.2999
doi: 10.1002/cam4.2999 pubmed: 32233081 pmcid: 7286449
Shapiro PJ, Coyne JC, Kruus LK et al (2004) Interest in services among prostate cancer patients receiving androgen deprivation therapy. Psychooncology 13:512–525. https://doi.org/10.1002/pon.769
doi: 10.1002/pon.769 pubmed: 15295773
Donovan JL, Hamdy FC, Lane JA et al (2016) Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 375:1425–1437. https://doi.org/10.1056/NEJMoa1606221
doi: 10.1056/NEJMoa1606221 pubmed: 27626365 pmcid: 5134995
Griesshammer E, Adam H, Sibert NT, Wesselmann S (2020) Implementing quality metrics in European Cancer Centers (ECCs). World J Urol 39:49–56. https://doi.org/10.1007/s00345-020-03165-4
doi: 10.1007/s00345-020-03165-4 pubmed: 32253584
Ansmann L, Kowalski C, Pfaff H (2018) Work organization in breast cancer centres – do hospitals structures account for differences? In: M Körner, Ansmann L, Schwarz B, Kowalski C (eds) Organizational Behaviour in Healthcare – Theoretical Approaches, Methods and Empirical Results. LIT Verlag, Wien, branch office Zürich, pp 107–134
Colloca G, Colloca P (2016) The effects of social support on health-related quality of life of patients with metastatic prostate cancer. J Cancer Educ 31:244–252
doi: 10.1007/s13187-015-0884-2
Bayer O, Billaudelle F, Alt J et al (2020) Was Männer davon abhält, ambulante Krebsberatungsstellen aufzusuchen. Eine qualitative Studie Onkologe 26:1047–1055. https://doi.org/10.1007/s00761-020-00840-4
doi: 10.1007/s00761-020-00840-4

Auteurs

Clara Breidenbach (C)

German Cancer Society, Berlin, Germany. breidenbach@krebsgesellschaft.de.

Lena Ansmann (L)

Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany.

Nora Tabea Sibert (NT)

German Cancer Society, Berlin, Germany.

Simone Wesselmann (S)

German Cancer Society, Berlin, Germany.

Sebastian Dieng (S)

OnkoZert GmbH, Neu-Ulm, Germany.

Ernst-Günther Carl (EG)

Bundesverband Prostatakrebs Selbsthilfe e. V., Bonn, Germany.

Günter Feick (G)

Bundesverband Prostatakrebs Selbsthilfe e. V., Bonn, Germany.

Cindy Stoklossa (C)

Deutsche Vereinigung für Soziale Arbeit im Gesundheitswesen e. V., Berlin, Germany.
Arbeitsgemeinschaft Soziale Arbeit in der Onkologie, Berlin, Germany.

Anne Taubert (A)

Deutsche Vereinigung für Soziale Arbeit im Gesundheitswesen e. V., Berlin, Germany.
Arbeitsgemeinschaft Soziale Arbeit in der Onkologie, Berlin, Germany.

Amanda Pomery (A)

Movember Foundation, Melbourne, Australia.

Burkhard Beyer (B)

Martini-Klinik, Prostate Cancer Center Hamburg, Hamburg, Germany.

Andreas Blana (A)

Klinik für Urologie und Kinderurologie, Klinikum Fürth, Fürth, Germany.

Marko Brock (M)

Department of Urology, Stiftungsklinikum Proselis, Recklinghausen, Germany.

Florian Distler (F)

Urologische Klinik der Universitätsklinik der Paracelsus Medizinischen Privatuniversität am Klinikum Nürnberg, Nürnberg, Germany.

Michael Enge (M)

Klinik für Urologie und Andrologie, Klinikum St. Georg, Leipzig, Germany.

Amr A Gaber (AA)

Carl-Thiem-Klinikum Cottbus, Cottbus, Germany.

Christian Gilfrich (C)

Klinikum St. Elisabeth Straubing, Straubing, Germany.

Andreas Hinkel (A)

Klinik für Urologie, Franziskus Hospital Bielefeld, Bielefeld, Germany.

Björn Kaftan (B)

Urologische Klinik, Städtisches Klinikum Lüneburg, Lüneburg, Germany.

Thomas Knoll (T)

Department of Urology, Klinikum Sindelfingen-Boeblingen, Sindelfingen, Germany.

Frank Kunath (F)

Department of Urology, University Hospital Erlangen, Erlangen, Germany.

Simba-Joshua Oostdam (SJ)

Klinikum Siloah Hannover, Hannover, Germany.

Inga Peters (I)

Clinic for Urology and Urologic Oncology, Hannover Medical School, Hannover, Germany.

Bülent Polat (B)

Department of Radiation Oncology, University of Würzburg, Würzburg, Germany.

Valentin Schrodi (V)

Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany.

Friedemann Zengerling (F)

Department of Urology, Ulm University Hospital, Ulm, Germany.

Christoph Kowalski (C)

German Cancer Society, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH